Bioptimus

🚀 Introducing H-optimus-1: the leading foundation model for histology, developed by Bioptimus. Trained on over 1 million whole-slide images from 800,000+ patients, H-optimus-1 sets a new performance benchmark in computational pathology. It outperforms existing models across key tasks—including tissue type classification, tumor grading, and biomarker prediction—spanning over 50 organs. The model is advancing precision medicine and research through critical applications, such as: 🧬 Biomarker discovery & patient stratification 💊 Drug discovery & preclinical validation 👩🔬 Accelerating clinical trials & regulatory approvals 🔬 Enhancing digital pathology & AI-assisted diagnosis H-optimus-1 is the first step in our mission to build a multi-scale, multimodal foundation model for biology. By integrating histology with other biological data types, breaking down silos in biology to give us a full understanding we aim to unlock the next generation of AI-powered precision medicine. Learn more about H-optimus-1: https://lnkd.in/etbBDgSK Explore our multimodal foundation model: https://lnkd.in/e_Hreivt

A glimpse into the Bioptimus DNA ⚡ In this case study with neptune.ai, you’ll meet our brilliant team pushing the boundaries of foundation models for biology to transform medical research—faster discoveries, fewer failed trials, and ultimately, better outcomes for patients. We’re excited to share how we work, and grateful to Neptune.ai for powering our large-scale experimentation journey. 📺 Check-out the video!

🎙️ Zelda Mariet, our VP of Research, shares her insights on the future of AI in biology in the latest #HumansInAI podcast. Her discussion about the difference between everyday AI and the models needed for science gets to the very heart of our mission: building foundational models that can truly understand the complexities of biology. A must-listen episode. #ScientificAI #FoundationModels

🎉 We’re thrilled to welcome Tokuwa Kanno as Head of Computational Biology! Tokuwa is an accomplished leader in computational biology and AI-driven drug discovery. He joins from GSK, where he led a team of computational biologists focused on leveraging large-scale biological data and AI to advance oncology pre-clinical and translational research. Previously, he held pivotal roles at Sanofi and Johnson & Johnson, where his research focussed on unlocking new insights into disease biology, drug mechanisms of action and drug-resistance biomarkers. Tokuwa will bring his deep biopharma expertise into the core design of our foundation model, providing the critical scientific direction to ensure we continue to tackle the most valuable real-world problems in drug discovery and translational research. The addition of the two new exceptional leaders to our team, Ketan Patel as Head of Product and Tokuwa as Head of Computational Biology, marks a new chapter in our mission to place users and biological insight at the centre of foundation model development. Welcome to the team, Tokuwa! 🧬 🔗 https://lnkd.in/dp6SFHMJ #Biotech #AIforBiology #FoundationModels

🎉 We’re thrilled to welcome Ketan Patel as Head of Product! Ketan brings over two decades of experience driving innovation at the intersection of data, AI, and life sciences. Most recently, Ketan served as VP of Product Strategy at Clarivate, where he shaped solutions for pharmaceutical R&D and evidence-based decision-making. Prior to Clarivate, he held senior product leadership roles at AstraZeneca, Oracle, Pfizer, and Eli Lilly, where he led the development of digital tools and platforms to accelerate drug discovery and development. Ketan will place our users at the heart of innovation, working closely with the scientific community and industry clients to gather insights and transform our foundation model into a powerful platform that accelerates breakthrough discoveries. The addition of the two new exceptional leaders to our team, Ketan as Head of Product and Tokuwa Kanno as Head of Computational Biology, marks a new chapter in our mission to place users and biological insight at the center of foundation model development. Welcome to the team, Ketan! 🧬 🔗 https://lnkd.in/dp6SFHMJ #Biotech #AIforBiology #FoundationModels

🇫🇷 Last week, our team reconnected in the beautiful French countryside for our summer offsite! From a collaborative hackathon on the multi-modal future of AI in biology to social activities, our ‘team-first’ mindset brought us together for bike rides and daily runs, while sparking innovative ideas. We believe that pioneering work should be a source of energy and inspiration. If you're ready to tackle the impossible, join us: https://lnkd.in/dB4wDXeM #LifeAtBioptimus #AIforBiology

🎉 We're thrilled to welcome Julie Gerardi as Bioptimus's first Chief Commercial Officer! A biotech industry veteran with 25+ years of experience, Julie has been part of building pioneering life science businesses across the most exciting and fast-growing biotech startups and Fortune 500 companies, like Parse, Tempus, Definiens and Astra Zeneca. Julie will spearhead our mission to transform how biological research and drug development are conducted, driving strategic partnerships and commercial initiatives that will bring the power of foundation models to the global life sciences community. Welcome to the team, Julie! 🧬 #Bioptimus #AIforBiology #FoundationModels #Biotech

🗓️ Happening today at 13:30 CEST. We look forward to the discussion with our co-founder, Felipe Llinares-López, and COO, Mathilda Strom, at the Foundational Models in Biology webinar. There is still time to join the conversation live: https://lnkd.in/dEAZfRyb #FoundationModels #Biotechnology #AIforBiology

Our co-founder, Felipe Llinares-López, and COO, Mathilda Strom, will be featured speakers at Plug and Play Health upcoming webinar, Foundational Models in Biology, on July 9th. Join them and other leading experts from Helmholtz Munich and World Fund to explore how powerful models such as M-optimus and H-optimus-1 are accelerating breakthroughs in life sciences, from drug discovery to personalized medicine. 🔗 Register here to attend: https://lnkd.in/dEAZfRyb #FoundationModels #Biotechnology #AIforBiology

🤖 We're launching a new function at Bioptimus: AI Operations. We're thrilled to welcome exceptional talents Ricardo Eleutério de Oliveira and Hector Parmantier, ML engineers with multi-functional skillsets honed through consulting and start-ups. They'll be working alongside our COO Mathilda Strom to build this new critical function from the ground up. Our vision for #Operations at Bioptimus is straightforward: build a team of agents and people that keeps us fast, radically efficient, and focused on our end goal. We're creating #agentic workflows across all #automatable parts of the business, freeing our people to focus on what only they can do—the complex judgment calls that build #foundationmodels to drive #breakthroughs in #biology. Building the future of biology requires rethinking everything, including how we work. #FutureofWork #FoundationModels #AIOperations